Syngene International Ltd
Results - Financial Results for quarter ended June 30, 2026
RESULTS
▼ Concern Flagged
MEDIUM RISK
📅 Filed on BSE: 29 Jul 2026, 05:54 PM IST · BSE ID: b44df3ef-7fb4-4438-a723-1664f65d53f0
View Original BSE Filing (PDF)
💡
In Simple Terms
Syngene International's latest financial report shows a consolidated loss of Rs. 90 million for the quarter.
🤖 AI Summary
- Consolidated Profit for the period was (Rs. 90) million for the quarter ended June 30, 2026.
- Consolidated Revenue from operations stood at Rs. 7,360 million for the quarter.
- Consolidated Basic Earnings per share was (Rs. 0.22) for the quarter ended June 30, 2026.
- The Board of Directors approved the unaudited standalone and consolidated financial results on July 29, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Consolidated Revenue from operations
Rs. 7,360 million
Consolidated Total Income
Rs. 7,613 million
Consolidated Profit for the period
(Rs. 90) million
Consolidated Basic Earnings per share
(Rs. 0.22)
Standalone Profit for the period
(Rs. 21) million
Standalone Revenue from operations
Rs. 6,630 million
🏢 How This Affects the Company
The reduction in Revenue from operations indicates a decline in demand or operational capacity compared to the preceding and corresponding prior quarters. The company operates in a single segment of Contract Research and Manufacturing Services.
The recorded loss for the period affects the company's profitability, contributing to a negative Basic Earnings per share for the quarter. Increased finance costs and foreign exchange fluctuation losses also impacted the financial outcome.
The company is in the process of liquidating Syngene Manufacturing Solutions Limited from June 15, 2026, which impacts its operational structure. Despite this, the company's total single-use bioreactor capacity had increased to 50,000L following a prior acquisition.
The reported loss and negative Earnings per share introduce financial performance risk for the company. Foreign exchange fluctuation loss, net, of Rs. 501 million highlights exposure to currency volatility.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, as reflected in the consolidated Basic Earnings per share of (Rs. 0.22) for the quarter ended June 30, 2026.
🔍
Management Signal
The management's approval of the unaudited results signals transparency regarding the company's financial performance, including the reported loss and revenue decline.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Next quarter's financial results — check for revenue recovery and profitability.
Updates on the liquidation of Syngene Manufacturing Solutions Limited.
Any further disclosures on foreign exchange fluctuation management.
MEDIUM RISK
The company reported a consolidated loss for the quarter and negative earnings per share, indicating financial pressure.
💡 Investor Takeaway
Syngene International's consolidated Profit for the period was (Rs. 90) million for the quarter ended June 30, 2026, a decrease from Rs. 867 million in the corresponding prior quarter. Consolidated Revenue from operations stood at Rs. 7,360 million, down from Rs. 8,745 million YoY.
⚖️ Strengths & Concerns
⚠️ Concerns
- Consolidated Profit for the period was (Rs. 90) million for Q1 FY27, a decline from Rs. 867 million in Q1 FY26.
- Consolidated Revenue from operations decreased to Rs. 7,360 million from Rs. 8,745 million in the corresponding prior quarter.
📅 Company Track Record
In FY26, Syngene International's profit fell 34.9% to Rs. 3,049 million. The board had approved a Re. 1.25 dividend and auditor reappointment on April 29, 2026. The company also approved the allotment of 7,29,727 equity shares on April 29, 2026.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Syngene International's consolidated profit for the quarter ended June 30, 2026?
Syngene International's consolidated Profit for the period was (Rs. 90) million for the quarter ended June 30, 2026.
What was Syngene International's consolidated revenue from operations in Q1 FY27?
Consolidated Revenue from operations for Syngene International was Rs. 7,360 million for the quarter ended June 30, 2026.
What was the consolidated Basic Earnings per share for Syngene International in Q1 FY27?
The consolidated Basic Earnings per share for Syngene International was (Rs. 0.22) for the quarter ended June 30, 2026.
How did Syngene International's consolidated profit compare to the corresponding quarter in the previous year?
The consolidated Profit for the period was (Rs. 90) million for the quarter ended June 30, 2026, compared to Rs. 867 million in the corresponding three months ended June 30, 2025.
Questions based on this BSE filing only. For information purposes.